Maria Rappai, MD
Pulmonary Disease · Jackson, MSNPI 1972597961
Payments from drug & device makers
Across 475 payments — averaging $94.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Dompe Farmaceutici S.p.a.$25K
- Intuitive Surgical$11K
- GSK$4K
- Inspire Medical Systems, Inc.$1K
- Abiomed$589
- Actelion Pharmaceuticals US, Inc.$566
- plus $3K from 21 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Dompe Farmaceutici S.p.a. | 37 | $25,266 |
| Intuitive Surgical | 52 | $11,112 |
| GSK | 229 | $3,760 |
| Inspire Medical Systems, Inc. | 11 | $1,219 |
| Abiomed | 13 | $589 |
| Actelion Pharmaceuticals US, Inc. | 18 | $566 |
| Insmed, Inc. | 36 | $505 |
| Sanofi | 3 | $246 |
| AstraZeneca | 10 | $242 |
| Merck | 6 | $219 |
| Jazz Pharmaceuticals Inc. | 8 | $170 |
| Johnson & Johnson | 9 | $138 |
| Ceribell, Inc. | 1 | $132 |
| United Therapeutics Corporation | 1 | $117 |
| Pfizer | 6 | $112 |
| Siemens Medical Solutions USA, Inc. | 1 | $103 |
| E.r. Squibb & Sons, L.L.C. | 7 | $98 |
| Gilead | 5 | $86 |
| Novartis | 5 | $71 |
| Boehringer Ingelheim | 4 | $69 |
| Mallinckrodt Hospital Products Inc. | 3 | $65 |
| Inari Medical, Inc. | 4 | $64 |
| Genentech USA, Inc. | 2 | $33 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| Covidien LP | 1 | $20 |
| Mylan Specialty L.p. | 1 | $20 |
| Eisai Inc. | 1 | $14 |
How this compares
$45,063 in reported general payments places this provider in the 90th percentile of 101 pulmonary disease providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Jackson
- Demondes HaynesJackson$809K
- Michal SenitkoJackson$355K
- Andrew WilhelmJackson$164K
- Raymond PortisJackson$39K
- Kimberly DobbsJackson$35K
- George AbrahamJackson$23K
- Arash SamarghandiJackson$19K
- Richard WellsJackson$19K
- Rajesh PatelJackson$13K
- Charles EvansJackson$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.